Conditions: Major Depressive Disorder
Keywords: Major Depressive Disorder MDD Depression
Enrollment: 269
Healthy volunteers: no

Brief summary:
This is a 6-month, open-label, flexible-dose study evaluating desvenlafaxine succinate sustained release (DVS SR) in the treatment of child and adolescent outpatients with major depressive disorder (MDD).

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: DVS SR
Intervention descriptions: intervention 1: Subjects will receive a flexible-dose of 20, 25, 35 or 50 mg/day as prescribed by the investigator.

Protocol document: